ArticleClinical cancer research : an official journal of the American Association for Cancer Research2012

Targeting Stat3 abrogates EGFR inhibitor resistance in cancer.

Malabika Sen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.